HSBC analyst Alexandre Falcao upgrades Copa Holdings (NYSE:CPA) from Hold to Buy.
Maxim Group Initiates Coverage On Zivo Bioscience with Buy Rating, Announces Price Target of $9
Maxim Group analyst Anthony Vendetti initiates coverage on Zivo Bioscience (NASDAQ:ZIVO) with a Buy rating and announces Price Target of $9.